Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Biodesix Inc (BDSX)

Biodesix Inc (BDSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 173,106
  • Shares Outstanding, K 145,467
  • Annual Sales, $ 49,090 K
  • Annual Income, $ -52,150 K
  • EBIT $ -35 M
  • EBITDA $ -24 M
  • 60-Month Beta 1.22
  • Price/Sales 3.67
  • Price/Cash Flow N/A
  • Price/Book 6.48

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 87.44%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.07
  • Number of Estimates 1
  • High Estimate -0.07
  • Low Estimate -0.07
  • Prior Year -0.10
  • Growth Rate Est. (year over year) +30.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1100 +8.11%
on 11/20/24
1.7200 -30.23%
on 10/23/24
-0.4000 (-25.00%)
since 10/21/24
3-Month
1.1100 +8.11%
on 11/20/24
2.0400 -41.18%
on 08/30/24
-0.5800 (-32.58%)
since 08/21/24
52-Week
1.1100 +8.11%
on 11/20/24
2.2100 -45.70%
on 02/05/24
-0.1200 (-9.09%)
since 11/21/23

Most Recent Stories

More News
Biodesix Announces Third Quarter 2024 Results and Highlights

BDSX : 1.2000 (+0.84%)
Biodesix to Participate in Three Investor Conferences in November

BDSX : 1.2000 (+0.84%)
Why Shares of CareDx Are Jumping Friday

The company's diagnostic tests may obtain better coverage from the Centers for Medicare & Medicaid Services.

BDSX : 1.2000 (+0.84%)
CDNA : 22.58 (+0.94%)
Biodesix to Report First Quarter 2023 Financial Results on May 11, 2023

Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus on lung disease, announced today that it will release financial results for first quarter ended March 31,...

BDSX : 1.2000 (+0.84%)
Biodesix Announces Fourth Quarter and Fiscal Year End 2022 Results and Highlights

Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced its financial and operating results for the fourth quarter and year ended...

BDSX : 1.2000 (+0.84%)
Biodesix to Participate at Cowen’s 43rd Annual Healthcare Conference

Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, announced today that Scott Hutton, Chief Executive Officer of Biodesix, will participate...

BDSX : 1.2000 (+0.84%)
Biodesix to Report Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023

Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus on lung disease, announced today that it will release financial results for the fourth quarter and year ended...

BDSX : 1.2000 (+0.84%)
Biodesix Announces First Four Private Payer Coverage Policies for the Nodify XL2® Test

Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced positive coverage decisions from four private payers including Blue Cross...

BDSX : 1.2000 (+0.84%)
Biodesix Announces Appointment of Lawrence (Lair) T. Kennedy, Jr. to Board of Directors

Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced the appointment of Lawrence (Lair) T. Kennedy, Jr. to the Company’s Board...

BDSX : 1.2000 (+0.84%)
Biodesix Ranked Top Proteomics Solutions Company by Life Sciences Review Magazine

Biodesix, Inc . (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, announced today that the Company was named the leading Proteomics Solutions Company in the...

BDSX : 1.2000 (+0.84%)

Business Summary

Biodesix Inc. is a data-driven diagnostic solutions company. It offers blood-based tests across the lung cancer continuum of care. The company also offers include diagnostic research, clinical research, development, and testing services to biopharmaceutical companies, as well as develops and commercializes...

See More

Key Turning Points

3rd Resistance Point 1.4050
2nd Resistance Point 1.3400
1st Resistance Point 1.2700
Last Price 1.2000
1st Support Level 1.1350
2nd Support Level 1.0700
3rd Support Level 1.0000

See More

52-Week High 2.2100
Fibonacci 61.8% 1.7898
Fibonacci 50% 1.6600
Fibonacci 38.2% 1.5302
Last Price 1.2000
52-Week Low 1.1100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar